Science Translational Medicine is a weekly biomedical journal of research at the intersection of science, medicine, and engineering that advances human health.
Science Translational Medicine publishes research advancing clinical medicine, bridging the gap between basic science and medical practice.
Home Science Translational Medicine Vol. 17, No. 824 Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus
Hypoxia-inducible factors link poor glycemic control to diabetic retinopathy by Yusuke Ichiyama Przemyslaw Sapieha Science Translational Medicine Vol. 17, NO. 796 30 Apr 2025 Focus
Home Science Translational Medicine Vol. 18, No. 839 Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome Research Article RETT SYNDROME
Home Science Translational Medicine Vol. 17, No. 802 DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosis Research Article HEMATOLOGICAL DISEASE
News Medical: The BII & Science Translational Medicine Prize launched for recognizing breakthroughs in women's health
In collaboration with the BioInnovation Institute (BII), AAAS is announcing the establishment of the BII & Science Translational Medicine Prize for Innovations in Women's Health. Submissions are now ...
The BII & Science Translational Medicine Prize launched for recognizing breakthroughs in women's health
Morningstar: PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug ...
PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically ...
PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug ...
Yahoo Finance: Seaport Therapeutics Announces Science Translational Medicine Peer-Reviewed Publication Featuring GlyphAlloTM (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve ...